Discover the roles of Responsible AI and model management in AI governance, where governance fits in the progression of AI maturity, and more.Learn More
The pharmaceutical industry’s highly regulatory environment can be tremendously demanding for organizations navigating the space. One of the biggest concerns that the pharmaceutical industry constantly attempts to address is the safety of its products and integrity of data used to make product-related safety decisions, a concern aimed to be addressed by GxP, a collection of regulations for good practices used in pharmaceuticals.
In October 2020, Dataiku was qualified by Merck’s internal audit and review process as supporting GxP compliance, which has enabled Merck’s use of Dataiku’s collaborative data science platform in production with regulated data. Here, we’ll cover what GxP is and why it’s so important, what the achievement means for both Merck and Dataiku, and, more broadly, how pharmaceutical companies can scale their data initiatives with Dataiku.
- Founded in 1668 in Darmstadt, Germany, Merck is a team of specialists in healthcare, life science, and performance materials with a love of science and passion for technology.
- ~57,000 employees
- € 16.2 billion in sales across 66 countries in 2019